EAGLE PHARMACEUTICALS
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch EGRX and buy or sell other stocks, ETFs, and their options commission-free!About EGRX
Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include RYANODEX, BENDEKA and BELRAPZO.
CEOMichael Graves
CEOMichael Graves
Employees135
Employees135
HeadquartersWoodcliff Lake, New Jersey
HeadquartersWoodcliff Lake, New Jersey
Founded2007
Founded2007
Employees135
Employees135
EGRX Key Statistics
Market cap2.87M
Market cap2.87M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume2.76K
Average volume2.76K
High today$0.22
High today$0.22
Low today$0.22
Low today$0.22
Open price$0.22
Open price$0.22
Volume263.00
Volume263.00
52 Week high$3.87
52 Week high$3.87
52 Week low$0.01
52 Week low$0.01
Stock Snapshot
EAGLE PHARMACEUTICALS(EGRX) stock is priced at $0.22, giving the company a market capitalization of 2.87M.
On 2025-12-18, EAGLE PHARMACEUTICALS(EGRX) stock moved within a range of $0.22 to $0.22. With shares now at $0.22, the stock is trading 0.0% above its intraday low and 0.0% below the session's peak.
Trading volume for EAGLE PHARMACEUTICALS(EGRX) stock has reached 263, versus its average volume of 2.76K.
Over the past 52 weeks, EAGLE PHARMACEUTICALS(EGRX) stock has traded between a high of $3.87 and a low of $0.01.
Over the past 52 weeks, EAGLE PHARMACEUTICALS(EGRX) stock has traded between a high of $3.87 and a low of $0.01.
People also own
Based on the portfolios of people who own EGRX. This list is generated using Robinhood data, and it’s not a recommendation.